The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy
Alex Farr(Medical University of Vienna), Christian F. Singer(Comprehensive Cancer Center Vienna), Lukas Baumann(Statistics Austria), Elisabeth Oppolzer(Medical University of Vienna), Georg Pfeiler(Medical University of Vienna), Myriam Stolz(Medical University of Vienna), Michael Seifert(Zimmer Biomet (Germany)), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna)
Cited by 35
Related Papers
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
|Annals of Oncology|2022|461
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422